Where Industry Meet Trends

ai robot image

Shares of Piramal Pharma Ltd. surged more than 13% following the announcement of its first profitable quarter in three quarters. The positive financial results were attributed to the notable growth in the company’s contract development and manufacturing organisations, as well as its complex hospital generics segments. According to official company disclosures, these segments witnessed a sequential increase of 26% and 37%, respectively. The encouraging financial performance of Piramal Pharma Ltd. in the March quarter led to a significant boost in the company’s stock value.

Read more from Bqprime

Leave a Reply

Your email address will not be published. Required fields are marked *

en_USEnglish